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Abstract
We investigate the effects of intermittent hypoxia (IH), a characteristic feature of obstructive
sleep apnea (OSA), on renal cancer progression in an animal and cell model. An in vivomouse
model (Balb/c, n = 50) of kidney cancer was used to assess the effect of IH on tumor growth,
metastatic capacity, angiogenesis and tumor immune response. An in vitromodel tested the
effect of IH on RENCA cells, macrophages and endothelial cells. Tumor growth, metastatic
capacity, circulating vascular endothelial growth factor (VEGF) and content of endothelial cells,
tumor associated macrophages and their phenotype were assessed in the tumor. In vitro,
VEGF cell expression was quantified.Although IH did not boost tumor growth, it significantly
increased endothelial cells (p = 0.001) and circulating VEGF (p<0.001) in the in vivomodel.
Macrophages exposed to IH in vitro increased VEGF expression, whereas RENCA cells and
endothelial cells did not. These findings are in keeping with previous clinical data suggesting
that OSA has no effect on kidney cancer size and that the association observed between OSA
and higher Fuhrman grade of renal cell carcinomamay bemediated though a proangiogenic
process, with a key role of macrophages.
Introduction
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder among adult population
and is characterized by recurrent occlusions of the upper airway during sleep hours leading to
intermittent hypoxia (IH) [1]. The most common risk factors of OSA are age, male gender and
obesity [2]. Patients suffering from OSA present increased levels of oxidative stress, systemic
inflammation and hypoxia-inducible factors (HIF) including their downstream gene products
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such as vascular endothelial growth factor (VEGF), a regulator and promoter of angiogenesis
[3,4]. A growing body of evidence based on large observational population-based studies sup-
ports a link between OSA and an increase in cancer incidence and mortality [5–7]. For kidney
cancer in particular, a higher incidence among patients with OSA has been recently reported
[7], and an association between OSA and high Fuhrman grade among patients undergoing
surgery for clear cell renal cell carcinoma (ccRCC) has been described [8]. It has been hypothe-
sised that IH in early cancers may select for specific genotypic and phenotypic properties that
persist even in normoxic conditions and may promote tumor progression and resistance to
therapy [9].
Better understanding of the pathophysiology of RCC in recent years has shown the impor-
tant role of hypoxia through HIF-1α pathways [10–13], which has led to successful application
of antiangiogenic drugs targeting VEGF [14]. Thus, HIF-1α and its downregulated genes have
an important role in the pathophysiology of both OSA and RCC. In fact, increased levels of
VEGF in response to IH have been previously described in a mouse melanoma model [15] and
clinically in patients with OSA [4,16].
The immune system is now considered to play a key role in tumor angiogenesis, invasion,
intravasation and metastasis [17]. In particular, tumor associated macrophages (TAMs) have
been reported as potentially involved in tumor growth. TAMs can have two different pheno-
types (M1 and M2). While M1 phenotype is associated to tumor inhibition, M2 phenotype is
related to tumor promotion [18]. In an animal model of lung cancer, mice undergoing IH pre-
sented an accelerated TAMs transition fromM1 to M2 phenotype [19].
Our primary hypothesis here is that IH promotes the synthesis of proangiogenic factors
such as VEGF, enhancing the neovascularization of the RCC tumor. Secondarily, we hypothe-
sized that in RCC, IH promotes a shift toward M2 phenotype in macrophages thereby trigger-
ing the proliferation of tumor cells, similar to what was observed in lung carcinoma [19].
Additionally, we aimed to investigate the potential sources of VEGF in response to IH from
different cell types involved in kidney cancer pathogenesis and known to produce VEGF
(RCC cells, macrophages and endothelial cells) [20,21]. Altogether, this study aims to provide
biological plausibility of those findings recently observed in OSA patients with ccRCC under-
going surgery [8].
Materials andmethods
Animals and cell lines
The study was approved by the Comitè Etic d’Experimentació Animal (CEEA) of the Universi-
tat de Barcelona (Permit number 192/15). All surgery was done under isoflurane anesthesia,
and all efforts were made to minimize suffering. The study was conducted on pathogen-free,
8-week-old Balb/c male mice (Charles River Laboratories, Saint Germain sur L’arbresle,
France). All animals were housed in controlled cages and were fed with standard rodent chow
(Panlab, Barcelona, Spain) and tap water ad libitum. They were all acclimated for one week
prior to the experiments and kept with 12:12 h light-dark cycle. All surgical procedures were
done under general anesthesia with intraperitoneal injection of a ketamine and xylazine combi-
nation (100mg/Kg; 10mg/Kg). Animals were monitored every 5 minutes throughout the experi-
mental procedure by observing that there was no change in respiratory rate associated with
surgical manipulation and toe pinch. Analgesia was procured with subcutaneous injection of
buprenorphine 0.05mg/Kg before the procedure and after it every 12 h during 72 h. Wet food
was put inside the cage during the first 24 h after the surgical procedure to facilitate feeding.
Immediately prior to euthanasia, isoflurane was mixed with mineral oil at a concentration of
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20% and placed inside the induction chamber. The maximum tumor size permitted during the
experiment was 1.2 cm in diameter.
A well stablished murine model of kidney adenocarcinoma based on RENCA cells (Ameri-
can Type Culture Collection (ATCC)-CRL-2947, Manassas, VA, USA) was used for in vivo
and in vitro experiments [22]. Kidney cancer cells were cultured in RPMI 1640 medium
(ATCC, 30–2001) supplemented with 10% fetal bovine serum (FBS) (Gibco 10270, Thermo
Fisher Scientific, Waltham, MA, USA), 100 U/ml penicillin and 100 μg/ml streptomycin
(Sigma-Aldrich, Missouri, USA). To assess the potential source of VEGF in vitro, mouse mac-
rophages RAW 264.7 and human primary aortic endothelial cells (HAEC) were also employed
in addition to RENCA cells. RAW 264.7 and HAEC cells were obtained from ATCC (TIB-71
and PCS-100-011, respectively). RAW 264.7 cells were cultured in high glucose Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/
ml streptomycin and 0.250 μg/ml amphotericin B and maintained at 37˚C and 5% CO2. In
other hand, HAEC cells were routinely grown in vascular cell basal medium supplemented
with endothelial cell growth kit-VEGF (ATCC) supplemented with an antibiotic/antimycotic
solution at final concentrations of 10 U/ml penicillin, 10 μg/ml streptomycin and 25 μg/ml
amphotericin B. All cell cultures were maintained in T-25 tissue culture flasks in a standard
humidified incubator at 20% O2, 5% CO2 and 37˚C prior to experimentation.
Application of intermittent hypoxia in vivo
The experimental setting for applying IHmimicking OSA in mice has been previously described
by our group [15]. The IH group was submitted to a continuous flow of gas cyclically switched
from room air (40 s) to a gas reservoir of hypoxic air at an oxygen fraction of 5% (20 s). The con-
trol group was identically instrumented but received room air (RA) all the time. Animals were
pre-exposed for two weeks to RA or IH prior to the subcutaneous or orthotopic RCCmodel
induction as detailed below.
Subcutaneous kidney cancer model: Assessment of tumor growth, cell
proliferation, angiogenesis, circulating VEGF levels and macrophage
polarization
A subcutaneous kidney tumor was induced into the right flank region in twenty-two mice (11
mice per group) injecting 2x105 RENCA cancer cells suspended in 100 μl of PBS subcutane-
ously. After twelve days, tumors were palpable and visible in all mice. After 21 days from
tumor induction, mice were anesthetized, exsanguinated and euthanized by cervical disloca-
tion. The tumors were immediately excised and weighted. Samples for immunohistochemistry
(IHC) and flow cytometry analysis were stored. Plasma samples were used to measure circulat-
ing VEGF by ELISA (Quantikine, R&D Systems, Minenapolis, USA), following the manufac-
turer’s protocol.
To carry out flow cytometry, seven tumor samples from each group were mechanically dis-
rupted in small pieces and digested in collagenase 1 mg/mL for 1 h in the shaker at 37˚C. Cells
were harvested and filtered through a 100 μMnylon mesh cell strainer (352350, BD Falcon,
Bedford, US). After washing the cells three times they were incubated for 30 minutes at 4˚C
and stained with surface markers antibodies. Endothelial cells were identified as CD31+ cells
and tumor associated macrophages (TAMs) as CD45+,CD11b+,F4/80+ cells. To evaluate cell
phenotype, CD206 and CD86 were added to the macrophage panel as M2 and M1 markers,
respectively. All antibodies were purchased from Biolegend (San Diego, US). Finally, the per-
centage of each cell type was quantified to assess the vascularization of the tumor and the con-
tent of macrophages and their polarization (M1 and M2).
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The rest of the samples from each group were fixed in formalin and embedded in paraffin
to stain the blood vessels (CD31+ cells) and quantify the proliferation rate (Ki-67 marker). The
paraffin blocks of the tumors were cut into 5 μm sections, dewaxed, rehydrated and prepared
using heat-induced epitope retrieval in citrate buffer, pH 6.0. Anti-CD31 (ab28364, Abcam,
Cambridge, UK) and anti-Ki67 (ab15580, Abcam, Cambridge, UK) rabbit polyclonal antibod-
ies were used following the manufacturer’s protocol. Sections were finally counterstained with
hematoxylin. Quantitative analysis was done using ImageJ (Wayne Rasband). Six fields from
each sample avoiding necrotic areas at x20 magnification for CD31+ and x40 magnification
for the Ki67 were used for the analysis. The selection of the fields and posterior analysis were
performed in blinded conditions.
Orthotopic kidney cancer model: Assessment of metastatic capacity
Twenty-eight mice were used to assess the metastatic capacity of IH. Animals were identically
randomized and subjected to either RA or IH as previously described. To generate this model,
the mice were anesthetized using 2–4% isoflurane (Baxter, Deerfield, US). The incision area
and its surroundings were shaved and cleaned with 70% ethanol and chlorhexidine scrub. A
5–10 mm incision was done in the outer skin layer of the right flank to expose the interior
muscle layer, which was then opened to expose the right kidney. The kidney was exteriorized
gently and the cell suspension (1x105 RENCA cells suspended in 20 μl of PBS) was injected
into the subcapsular space. Once the kidney was replaced to its original position, the interior
wall was closed with a Vicryl 3/0 (Ethicon, Somerville, US) and the skin with polypropylene
2/0 suture (Aragó, Barcelona, Spain). Subcutaneous buprenorphine (Buprex, RB Pharmaceuti-
cals Limited, UK) at a concentration of 0,05 mg/Kg was administered before the incision and
every 12 h for three days after the procedure. The skin suture was removed seven days after the
procedure.
After 20 days of tumor induction, mice were exsanguinated and sacrificed by cervical dislo-
cation under anesthesia. The lungs were then harvested, fixed in paraformaldehyde and
embedded in paraffin. Paraffin blocks were sectioned into 5 μm sections, stained with hema-
toxilyn/eosin and examined under light microscopy by a double-blind investigator. Total
number of metastasis and metastatic area was quantified using Metamorph image analysis
software (Molecular Devices, Sunnyvale, CA, USA).
Assessment of VEGF production in RENCA cells, macrophages and
endothelial cells exposed to IH in vitro
To assess the potential sources of VEGF under IH conditions, 5x104 RENCA cells, 15x104
RAW 264.7 cells and 6x104 HAEC cells were exposed to IH (cycles alternating 20% O2−1% O2
every 30 s) or continuous RA (21% O2) as previously described [23]. After 24 h, total RNA
from RENCA, RAW 264.7 and HAEC cell cultures were extracted using the RNeasy kit (Qia-
gen, Hilden, Germany). One μg was employed to synthesize cDNA by reverse transcription
polymerase chain reaction (TaqMan Reverse Transcription Reagents) according to manufac-
turers’ instructions. qPCR was performed using the Taqman Fast Advanced Master Mix and
the TaqMan Gene Expression Assays in a StepOnePlus thermocycler. Relative VEGF gene
expression normalized to eukaryotic 18S rRNA endogenous control was calculated using the
2-ΔΔCTmethod [24] to quantify fold change in VEGF gene expression compared to baseline.
All reagents were purchased from ThermoFisher Scientific (Waltham, MA) unless otherwise
noted.
IH and vascularization of RCC
PLOSONE | https://doi.org/10.1371/journal.pone.0179444 June 8, 2017 4 / 12
Statistical analysis
All data are presented as mean ± SE. T-student test was used to compare IH and RA groups.
Two-tailed P value of<0.05 was considered to achieve statistical significance. The Spearman
Rank correlation test was used to evaluate the correlation between plasmatic VEGF and endo-
thelial cells.
Results
Intermittent hypoxia induces tumor angiogenesis, macrophage
recruitment and increases systemic VEGF levels in the subcutaneous
model of RCC
At the end of the study, tumor sections revealed a 1.9-fold increase (p = 0.044) in the density of
vessels in those mice exposed to IH respect to RA (Fig 1A). The higher vessel density in tumors
of mice exposed to IH was also supported by the flow cytometry analysis. In particular, cell
density of vascular endothelial cells within the tumor stroma similarly experienced a ~2-fold
increase compared to the control group (p = 0.001) (Fig 1B). Plasma VEGF was significantly
overexpressed in the IH group, with a mean concentration of 306±93 pg/mL compared to
194±10 pg/mL in the normoxic control group (p<0.001) (Fig 1C). Interestingly, a positive sig-
nificant correlation was seen between circulating VEGF and endothelial cells (Rho = 0.42,
p = 0.003) (Fig 1D). In addition, the application of IH increased the density of TAMs (cells per
gram of tissue) on RENCA tumors. Specifically, TAMs density within the tumor under IH was
increased by ~58% compared to normoxia (p = 0.024) (Fig 1E and 1F). However, we did not
observe any change in the expression of the M1 (Fig 1G) and M2 (Fig 1H) surface markers of
TAMs evaluated from IH-exposed RENCA tumors. No differences on tumor weight (Fig 1I)
or proliferation rates (Fig 1J) were either observed.
Intermittent hypoxia do not promote metastatic capacity in the orthotopic
model of RCC
In the orthotopic model, performed to assess metastatic capacity, no differences on lung
metastases were observed between the study groups (Fig 2A). Specifically, the percentage of
lung metastatic area was 0.29±1.61% and 0.90±0.57% (median±SE, p = 0.446) in mice exposed
to RA and IH, respectively.
IH promotes VEGF production by macrophages in vitro
The application of IH in vitro revealed a different response in tumor cells (Fig 3A), macro-
phages (Fig 3B) and endothelial cells (Fig 3C). Specifically, VEGF expression of RENCA cells
exposed to IH for 24 h experienced a trend towards increased levels but the differences did not
reach statistical significance. On the other hand, IH promoted a ~50% increase in VEGF
expression in RAW 264.7 macrophages (p = 0.002) and no differences were observed in
HAEC cells.
Discussion
Application of IH mimicking OSA in our mouse model of kidney cancer markedly enhanced
angiogenesis, which is commonly considered as an important malignant prognostic factor in
kidney cancer [25]. HIF-1α pathways seem to have a role in ccRCC [10–13] and in other can-
cers, with context dependent roles [26]. In our study, elevated systemic levels of VEGF was
observed in response to IH, explaining the higher vessel formation assessed by flow cytometry
IH and vascularization of RCC
PLOSONE | https://doi.org/10.1371/journal.pone.0179444 June 8, 2017 5 / 12
Fig 1. Results from the subcutaneous RCCmodel: A) Application of intermittent hypoxia (IH) markedly
increased vascularization (stained in brown) compared to room air (RA) (scale bar 200 μm). B) Flow
cytometry analysis revealed similar increase in the number of endothelial cells within the tumors of mice
exposed to IH. C) Animals exposed to IH also presented increased circulating levels of VEGF which D)
correlated with tumor vascularization. E) Tumor-associated macrophages (TAMs) were identified as CD45+,
CD11b+ and F4/80+ cells by flow cytometry and F) their analysis revealed that IH promotes an increased cell
density of TAMs in comparison to room air (RA) conditions. However, IH did not change any of the markers G)
CD206 (pro-tumoral M2marker) and H) CD86 (anti-tumoral M1marker) studied. In both cases, representative
histograms on their expression are shown for RA and IH conditions. Despite the increased tumor vascularization
assessed under IH conditions, I) IH did not change tumor weight nor J) tumor cells proliferation measured by the
IH and vascularization of RCC
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immunohistochemical analysis of the Ki67 expression. Representative images of Ki67 staining obtained from
mice exposed to RA and IH are shown (scale bar 100 μm). Data is presented as mean ± SE. * p<0.05 and
*** p<0.001.
https://doi.org/10.1371/journal.pone.0179444.g001
Fig 2. Results from the orthotopic RCCmodel: No differences in themetastatic capacity of RCC tumors were
encountered between intermittent hypoxia (IH) and room air (RA) groups. The orange arrow points one of the
observed lung metastasis (stained in blue). The images represent different lung lobes from the same animal exposed
to either RA (top) or IH (bottom) (scale bar 5 mm).
https://doi.org/10.1371/journal.pone.0179444.g002
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Fig 3. VEGF relative gene expression measured in A) RENCA, B) macrophages and C) endothelial cells
showed a differential response to IH in vitro. Only macrophages presented a marked increase in VEGF
expression in response to IH. Data is presented as mean ± SE. ** p<0.01.
https://doi.org/10.1371/journal.pone.0179444.g003
IH and vascularization of RCC
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and histologically by IHC (Fig 1). In addition, the experiments carried out in vitro revealed the
importance of the immune system on angiogenesis, supporting the role of macrophages on
VEGF production in response to IH (Fig 3B).
In order to explore the potential relation between OSA and kidney cancer, we reviewed a
large series of patients with ccRCC and found an increased risk of having a high Fuhrman
grade in patients with OSA compared to those not diagnosed with OSA (51 vs. 38%; 13% risk
difference; 95% confidence interval (CI), 5–20) [8]. In the same study, a VEGF pathway en-
richment among OSA patients was suspected. However, there were no differences on tumor
size, metastasis-free survival or cancer-specific survival. Interestingly, the mouse kidney can-
cer model used in the present study reproduced most of these clinical findings observed in
humans, and no effect of IH on tumor growth (Fig 1I) and metastasis (Fig 2A) was seen.
IH has been associated with higher tumor growth [27], metastatic rates and mortality [28]
compared to normoxic controls in melanoma and lung adenocarcinoma mouse models. Inter-
estingly, this effect has not been reproduced in our RCCmodel. This fact could be explained in
part by a differential immune response observed in the RENCA tumor model compared to
previously reported findings [19]. In particular, lung adenocarcinoma cells are able to increase
the recruitment of resident macrophages from surrounding tissues and bone-marrow derived
monocytes and, most importantly, promote their shift towards a M2 phenotype under IH
conditions [19]. In fact, in vitro assays previously demonstrated that the co-culture of TAMs
isolated from tumors of mice exposed to IH is able to increase tumor cell proliferation, migra-
tion and invasion compared to TAMs isolated from the control group [19]. In our model of
RENCA, we did not observe a shift toward a more pro-tumoral phenotype (M2) (Fig 1). Thus,
the lack of IH-induced alterations on TAMs phenotype in our model could explain in part
the absence of tumor growth differences between groups. Remarkably, our results are in ac-
cordance with the available data from the clinical study where no changes on ccRCC tumor
growth or metastasis were observed in OSA patients. Further investigation is still needed to
understand the differential response of the immune system in kidney cancer compared to
other cancer types.
Microvessel density as a surrogate of angiogenesis has been described as an independent
prognostic factor for metastasis in human ccRCC [25]. Also, plasmatic levels of VEGF are
increased in patients with RCC and its level in serum correlates to clinical stage and histopath-
ological grade [29]. From this perspective, plasma VEGF levels were significantly increased in
mice subjected to IH, and had a local effect within the tumors, which were more vascularized
than those in the control group. Also, we explored the potential sources of VEGF in vitro in
order to investigate the potential contribution of tumor cells and other stromal cells such as
macrophages or endothelial cells on tumor vascularization. After 24 h of IH exposure, macro-
phages showed a clear increase in VEGF expression. Conversely, RENCA cells only presented
a trend towards increase in VEGF expression and no changes were observed in endothelial
cells (Fig 3). These results suggest that the increased tumor vascularization observed under IH
and explained by higher circulating VEGF levels is most likely due to an increased expression
of VEGF by other cell populations in tumor stroma such as macrophages rather than from
RENCA cells. Similar findings on VEGF levels and tumor vascularization were previously
observed in mice subjected to IH in a melanoma cancer model [15].
The use of animal and in vitromodels avoids the interaction of most common confounders
such as obesity or other metabolic disorders associated with OSA, which are well known to
promote cancer progression [30,31]. However, some limitations in our study should be men-
tioned. While our results reproduce most of the clinical findings from a patient based database
[8], the involved molecular mechanisms should be tested in humans or in tumor models from
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patients [32]. Also, whereas we only studied the effect of IH, other noxious factors associated
with OSA, such as sleep fragmentation, should be analyzed in the future [33].
Conclusions
Our animal model results are consistent with previous clinical data showing that OSA does
not modify RCC tumor size. Although the increased circulating levels of VEGF and tumor vas-
cularization found in mice subjected to IH do not translate into changes in tumor growth and
metastasis, they could participate in the increased Fuhrman grade observed clinically in OSA
patients undergoing surgery for a RCC. However, further studies are still needed to fully
understand the potential mechanisms that contribute to the increased malignancy observed
clinically in patients with OSA. In the context of the relationship between OSA and cancer, the
RCCmodel has a distinctive response to IH compared to other cancer models such as mela-
noma or lung adenocarcinoma, which highlights the importance of designing and performing
new clinical studies based on specific types of cancers.
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